View Clinical Trial (Medical Research Study)
Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy - NCT00927914-21231(Clinical Trial 299724)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Baltimore |
|
State:
|
|
MD |
| Zip Code: |
|
21231 |
| Conditions: |
|
Mild to Moderate Diabetic Sensorimotor Polyneuropathy. |
| Purpose: |
|
The purpose of this study is to determine the effect of 40 mg and 80 mg ranirestat on
peroneal motor nerve conduction velocity relative to placebo in subjects with mild to
moderate diabetic sensorimotor polyneuropathy.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Subjects with Type 1 or Type 2, insulin-dependent or non insulin-dependent diabetes
mellitus.
- Subjects with a history of distal symmetric polyneuropathy, secondary to diabetes,
diagnosed in accordance with the American Academy of Neurology criteria.
- Female subjects, who are of non-reproductive potential (≥12 months post-menopausal or
surgically sterile) or who are using adequate contraception which includes abstinence
or double barrier methods (diaphragm and condom with spermicidal cream, intrauterine
device and condom with spermicidal cream). Male subjects with partners of
child-bearing potential must also use adequate contraception.
- Subjects must be able to read, understand, and provide written informed consent
before enrolling in the study at screening.
Exclusion Criteria:
- History of diabetic foot ulcers or lower extremity amputation.
- Diabetic amyotrophy or non-diabetic cause of lower limb neuropathy/neuropathic
symptoms.
- Clinically significant illness which, in the opinion of the investigator, would
compromise a subject's suitability to participate in the study for reasons of safety
or would confound the efficacy assessments. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
January 6, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|